# Does Your Employer Cover a GLP-1 for Weight Loss? | Buy This GLP

See what the 2026 employer survey found about GLP-1 coverage for weight loss and how to check your plan’s eligibility, prescriber rules and copay.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/does-your-employer-cover-a-glp1
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Does Your Employer Cover a GLP-1 for Weight Loss?

KFF found that 18% of large employers reported GLP-1 coverage for weight loss in 2026. Here is how to check your own plan.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20269 min readUpdated November 2026

Large firms offering health benefits, 2026 · 18 cover a GLP-1 for weight loss · 82 did not report coverage in their largest plan. · Coverage for diabetes is a separate and much older question.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   In 2026, 18% of firms with at least 200 workers that offered health benefits reported coverage for GLP-1s used for weight loss in their largest plan.
-   The survey figures cover weight-loss use. Check your plan separately for a prescription for type 2 diabetes.
-   A survey of 518 full-time employees starting tirzepatide describes people who had already accessed treatment.
-   Among survey respondents with employer insurance, 55.9% reported coverage for obesity medication.
-   52.3% of those respondents said they would consider changing jobs to get that coverage.
-   After the FDA and Medicare policy changes, Wegovy fills rose 136.4% compared with the prepolicy period.

In KFF’s 2026 survey, 18% of employers with at least 200 workers that offered health benefits said their largest plan covered a GLP-1 for weight loss. Coverage differed by firm size: 16% vs. 33% for firms with 200 to 999 workers and firms with at least 5,000 workers, respectively. Among firms with 1,000 to 4,999 workers, 29% reported coverage[\[9\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-9). If your plan excludes it, compare [the full monthly cost of a GLP-1](https://buythisglp.com/research/how-much-does-a-glp1-cost-per-month) before budgeting for treatment.

## What the employer survey counts

KFF reported 19% in 2025[\[1\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-1). Both years describe the largest plan at firms with at least 200 workers that offered benefits. The question was about weight-loss use. Check the formulary for the reason your clinician prescribed the drug.

Two people prescribed the same drug at the same dose can pay different amounts because coverage depends on the diagnosis and the plan’s rules. The [GLP-1 insurance guide](https://buythisglp.com/research/does-insurance-cover-glp1) explains what to compare when you have both a plan estimate and a cash quote. Check whether either amount excludes care or pharmacy charges.

## What employer coverage can still cost

In KFF’s 2026 survey, family premiums averaged $28,303 a year. Covered workers contributed an average of $7,471 a year toward family coverage. Among workers with single coverage and a general annual deductible, that deductible averaged $1,955[\[9\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-9). Ask your plan for the prescription’s cost separately, since the premium and general deductible alone do not tell you what you would pay at the pharmacy.

## Who the tirzepatide survey measured

A survey of 518 full-time employed US adults who were starting tirzepatide found that 80.9% had employer-provided insurance. Among those with employer insurance, 55.9% reported coverage for obesity medication[\[2\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-2). KFF surveyed employers. This study surveyed employees who had accessed treatment.

The survey did not include people who never started treatment. For a different view of access, see our analysis of [the people offered a prescription who declined it](https://buythisglp.com/research/why-do-people-turn-down-a-glp1-prescription).

Everyone surveyed had already chosen the drug

In this sample, 96.5% supported employer coverage for obesity medication. The survey recruited people already starting tirzepatide, so its result describes those respondents. The paper also discloses industry ties among its authors [\[2\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-2).

## What an employer is actually weighing

Our [summary of a survey of Swedish physicians](https://buythisglp.com/research/the-doctors-agree-and-cannot-prescribe) describes access barriers from a different health system. These employer figures describe U.S. benefit decisions.

Among the 518 surveyed employees who were starting tirzepatide, 52.3% said they would consider changing jobs to obtain coverage for obesity medication. Another 81.7% said that coverage could increase job satisfaction[\[2\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-2). The survey measured what those employees said they might do. It did not track whether they changed jobs.

The survey also measured self-reported work and activity impairment at baseline. It did not measure a change in impairment after treatment began.

## Wegovy fills rose after coverage expanded

In March 2024 the FDA expanded Wegovy’s indication for adults with established cardiovascular disease and overweight or obesity[\[10\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-10). Medicare Part D began covering it for that indication. The [Wegovy coverage analysis](https://buythisglp.com/research/wegovy-label-change-coverage) explains how the researchers counted Part D fills and describes the later Medicare demonstration. National prescription data show Wegovy fills increased 136.4% across payers. Part D fills rose from 4,689 in February to 32,732 in September 2024[\[3\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-3). The authors’ regression associated the policy changes with an estimated 592,624 additional fills by September 2024.

The [Medicare coverage guide](https://buythisglp.com/research/does-medicare-cover-ozempic-and-wegovy) explains how the condition being treated affects coverage. Check your own plan for the approved uses, eligibility requirements and out-of-pocket costs.

## What to ask, and who decides

Ask human resources or the plan for its current formulary and coverage criteria. Give them the product and the condition your clinician is treating. Ask whether the benefit uses a separate program and who can prescribe under it.

### When your plan uses 9amHealth

The [insurance coverage worksheet](https://buythisglp.com/tools/glp1-insurance-worksheet) gives you a place to record the program, prescribing and pharmacy rules your plan confirms. For example, 9amHealth’s SmithRx page describes an employer option that requires its own prescriber for covered weight-management GLP-1s[\[4\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-4). Ask whether that rule applies to your benefit.

9amHealth offers a program through employers[\[5\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-5). Its direct sign-up page currently takes waitlist requests[\[6\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-6). If your employer lists 9amHealth as a benefit, ask which enrollment link to use and what you would pay for the visit and the prescription.

Check who can write a covered prescription. The EncircleRx page describes a choice between your existing clinician and a 9amHealth clinician for that program[\[7\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-7). The [9amHealth member guide](https://join9am.com/for-individuals) lists Wegovy and Zepbound among the medications its care team may prescribe for eligible members. Ask which drug and pharmacy your plan covers. Also ask about the medication copay. The Amazon program, for example, offers care at no charge to eligible members but says medication cost-sharing may apply[\[8\]](https://buythisglp.com/research/does-your-employer-cover-a-glp1#ref-8).

If the drug is covered but approval is pending, the [prior authorization timeline](https://buythisglp.com/research/how-long-does-prior-authorization-take-for-a-glp1) explains when to check whether the plan received the request. Ask your benefits team who can confirm the status.

## Frequently asked

Does my employer have to cover a GLP-1 for weight loss?

Coverage varies by plan. In 2026, 18% of large employers offering health benefits reported covering GLP-1s for weight loss in their largest plan. Check the plan documents for your benefit.

Why do surveys of people taking the drug show much higher coverage?

This survey recruited 518 full-time employees who were already starting tirzepatide. Their experiences describe access among treatment starters and cannot establish coverage rates across the workforce.

Is coverage different if the prescription is for type 2 diabetes?

It can be. The KFF figures describe weight-loss use. Ask your plan whether it covers the specific product for type 2 diabetes and what requirements apply.

Would employees really change jobs over this?

52.3% of surveyed employees starting tirzepatide said they would consider it, and 81.7% said coverage could increase job satisfaction. Those are stated intentions rather than observed moves.

Where do I find out whether my plan covers it?

Ask human resources or the plan for the current formulary and coverage criteria. Verify the product, diagnosis, approval requirements, and pharmacy costs.

## Sources

1.  \[1\] KFF (2025). 2025 Employer Health Benefits Survey KFF. [Source](https://www.kff.org/health-costs/2025-employer-health-benefits-survey/)
2.  \[2\] Gibble TH, Al-Zubeidi T, Gerber C, Collins E, et al. (2026). Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey Obesity Pillars. [PMID 42518363](https://pubmed.ncbi.nlm.nih.gov/42518363/)
3.  \[3\] Scannell C, et al. (2026). Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies The American Journal of Managed Care. [PMID 42640207](https://pubmed.ncbi.nlm.nih.gov/42640207/)
4.  \[4\] 9amHealth (2026). 9amHealth for SmithRx members 9amHealth. [Source](https://join9am.com/smithrx)
5.  \[5\] 9amHealth (2026). 9amHealth for employers 9amHealth. [Source](https://fororganizations.join9am.com/)
6.  \[6\] 9amHealth (2026). Direct enrollment waitlist 9amHealth. [Source](https://join9am.com/coming-soon-direct)
7.  \[7\] 9amHealth (2026). 9amHealth for EncircleRx members 9amHealth. [Source](https://join9am.com/encirclerx)
8.  \[8\] 9amHealth (2026). Amazon’s weight management program 9amHealth. [Source](https://join9am.com/amazon)
9.  \[9\] KFF (2026). 2026 Employer Health Benefits Survey KFF. [Source](https://www.kff.org/health-costs/2026-employer-health-benefits-survey/)
10.  \[10\] U.S. Food and Drug Administration (2024). FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight FDA. [Source](https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
